Implantica AG reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was EUR 0.307 million compared to EUR 0.198 million a year ago. Net loss was EUR 4.55 million compared to EUR 4.78 million a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
27.25 SEK | +0.37% | +0.93% | +14.02% |
05-14 | Implantica AG Announces the Eighth RefluxStop? Center of Excellence in Italy | CI |
04-26 | Tranche Update on Implantica AG (OM:IMP A SDB)'s Equity Buyback Plan announced on April 6, 2023. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.02% | 710M | |
+73.66% | 12.43B | |
-18.82% | 8.09B | |
-2.44% | 6.12B | |
+16.74% | 5.59B | |
-14.69% | 5.47B | |
+46.20% | 5.23B | |
-16.51% | 4.1B | |
-27.87% | 2.65B | |
+1.73% | 1.99B |
- Stock Market
- Equities
- IMP A SDB Stock
- News Implantica AG
- Implantica AG Reports Earnings Results for the First Quarter Ended March 31, 2023